Nefcityl Tablet
Marketer
Accuren BioPharma
Salt Composition
Taurine (500mg) + Acetylcysteine (150mg)
Overview Nefcityl Tablet
Renalyte tablets combine medications to manage chronic kidney disease, safeguarding kidney function and mitigating the risk of renal failure. Administer Renalyte with or without food, following your physician's prescribed dosage and regimen. Dosage is individualized based on your health status and treatment response. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and disease progression. Inform your doctor of all other medications you're using, as interactions are possible. Common, usually transient, side effects include nausea, vomiting, fever, rhinorrhea, diarrhea, abdominal discomfort, skin reactions (rash, irritation), and pharyngitis. Report any concerning side effects promptly. Prior to commencing Renalyte, disclose any existing kidney or liver conditions and all other medications to your doctor. Pregnant or breastfeeding individuals should seek medical advice before use.
Major Benefits of Nefcityl Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Nefcityl Tablet with a meal.
Common Side effects of Nefcityl Tablet:
- Nausea
- Vomiting
- Rash
- Fever
- Runny nose
- Diarrhea
- Abdominal pain
- Skin irritation
- Throat irritation
How Nefcityl Tablet works:
Taurine and acetylcysteine, combined in Nefcityl tablets, offer dual antioxidant protection, safeguarding kidney cells from the damaging effects of free radicals.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Nefcityl Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Nefcityl Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Limited evidence indicates that Nefcityl Tablet may pose a risk to breastfeeding infants. The drug's potential transfer into breast milk and subsequent harm to the baby necessitate caution.
DrivingCONSULT YOUR DOCTOR
The effect of Nefcityl Tablet on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Nefcityl tablets pose no safety concerns for individuals with kidney disease; no dosage modification is necessary.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Nefcityl Tablet's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Nefcityl Tablet :
NA
Facts to Know About Nefcityl Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | The study of the urinary tract and male reproductive system. |
3,018 People bought this recently